Home » Topics » BioWorld Asia

BioWorld Asia
RSS

Objectors Say Public Voice Weighted To Favor GMOs

Feb. 3, 1999

Genetic Mutations Multiply To 'Incredibly' High Level

Feb. 3, 1999

Epidauros, Parexel Enter Pharmacogenomics Deal

Feb. 3, 1999

Biovector Launches IPO To Fund Growing Research

Feb. 3, 1999

Vanguard CEO Reassures Stockholders In Letter

Jan. 27, 1999

Algene Enters Two Deals, Moves Into Restructuring

Jan. 27, 1999

Pharmagene, SmithKline Sign Tissue-Testing Deal

Jan. 27, 1999

PowderJect, Glaxo Extend DNA Vaccines Agreement

Jan. 27, 1999

Cortecs' Restructuring Plan Cuts Staff, Closes Offices

Jan. 27, 1999

New Parkinson's Approach May Reduce Transplant Rate

Jan. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.